Tenax Therapeutics (TENX) Amortizatization of Intangibles (2014 - 2022)
Tenax Therapeutics' (TENX) quarterly Amortizatization of Intangibles came in at $27857.0 in Q4 2022, up 139.97% year-on-year from $11608.3 in Q4 2021, and up 2.03% quarter-over-quarter from $27303.0 in Q3 2022.
Tenax Therapeutics (TENX) Amortizatization of Intangibles (2014 - 2022) Analysis & Trends
Tenax Therapeutics has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting $27857.0 for Q4 2022.
- Amortizatization of Intangibles for Q4 2022 came in at $27857.0, up 139.97% year-over-year; the trailing twelve-month figure through Sep 2023 was $27857.0 (up 161.72% YoY), and the FY2022 annual result was $108189.0, up 1047.65% from the prior year.
- Amortizatization of Intangibles came in at $27857.0 for Q4 2022 at Tenax Therapeutics, up from $27303.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $104040.0 in Q4 2019 to a low of -$69688.0 in Q4 2021.
- The 5-year median for Amortizatization of Intangibles is $26841.0 (2020), against an average of $22213.7.
- Across the five-year window, Amortizatization of Intangibles surged 15727.75% in 2020 and plunged 344.45% in 2021, its largest moves.
- Tenax Therapeutics' Amortizatization of Intangibles stood at $91511.0 in 2018, then gained by 13.69% to $104040.0 in 2019, then plunged by 72.6% to $28508.0 in 2020, then plunged by 344.45% to -$69688.0 in 2021, then soared by 139.97% to $27857.0 in 2022.
- The last three Amortizatization of Intangibles figures came in at $27857.0 (Q4 2022), $27303.0 (Q3 2022), and $26772.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Tenax Therapeutics | 120.33 Mn | 120.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 27,857.00 |
| Dec 31, 2022 | 27,857.00 |
| Sep 30, 2022 | 27,303.00 |
| Sep 30, 2022 | 27,303.00 |
| Jun 30, 2022 | 26,772.00 |
| Jun 30, 2022 | 26,772.00 |
| Mar 31, 2022 | 26,257.00 |
| Mar 31, 2022 | 26,257.00 |
| Dec 31, 2021 | -69,688.00 |
| Dec 31, 2021 | -69,688.00 |
| Sep 30, 2021 | 25,256.00 |
| Sep 30, 2021 | 25,256.00 |
| Jun 30, 2021 | 49,417.00 |
| Jun 30, 2021 | 49,417.00 |
| Mar 31, 2021 | 4,442.00 |
| Mar 31, 2021 | 4,442.00 |
| Dec 31, 2020 | 28,508.00 |
| Dec 31, 2020 | 28,508.00 |
| Sep 30, 2020 | 27,940.00 |
| Sep 30, 2020 | 27,940.00 |